NO20084993L - Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene - Google Patents

Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene

Info

Publication number
NO20084993L
NO20084993L NO20084993A NO20084993A NO20084993L NO 20084993 L NO20084993 L NO 20084993L NO 20084993 A NO20084993 A NO 20084993A NO 20084993 A NO20084993 A NO 20084993A NO 20084993 L NO20084993 L NO 20084993L
Authority
NO
Norway
Prior art keywords
taste
genes
methods
umami
bitter
Prior art date
Application number
NO20084993A
Other languages
English (en)
Norwegian (no)
Inventor
Bryan Moyer
Min Lu
Fernando Echeverri
Dalia Kalabat
Na Gao
Peter Hevezi
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of NO20084993L publication Critical patent/NO20084993L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20084993A 2006-06-08 2008-11-28 Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene NO20084993L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81176306P 2006-06-08 2006-06-08
US83119906P 2006-07-17 2006-07-17
US84899506P 2006-10-04 2006-10-04
US86617806P 2006-11-16 2006-11-16
PCT/US2007/013502 WO2007146120A2 (en) 2006-06-08 2007-06-08 Rationale, methods, and assays for identifying novel taste cell genes and salty taste receptor targets and assays using these identified genes or gene products

Publications (1)

Publication Number Publication Date
NO20084993L true NO20084993L (no) 2008-11-28

Family

ID=38832404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084993A NO20084993L (no) 2006-06-08 2008-11-28 Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene

Country Status (10)

Country Link
US (1) US20080261824A1 (cg-RX-API-DMAC7.html)
EP (1) EP2024518A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009539377A (cg-RX-API-DMAC7.html)
AU (1) AU2007258511A1 (cg-RX-API-DMAC7.html)
CA (1) CA2654552A1 (cg-RX-API-DMAC7.html)
IL (1) IL195205A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008015314A (cg-RX-API-DMAC7.html)
NO (1) NO20084993L (cg-RX-API-DMAC7.html)
TW (1) TW200813232A (cg-RX-API-DMAC7.html)
WO (1) WO2007146120A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10078087B2 (en) 2001-05-01 2018-09-18 Senomyx, Inc. Assays and enhancers of the human delta ENaC sodium channel
MXPA06000266A (es) 2003-07-10 2006-03-30 Senomyx Inc Ensayos electrofisiologicos mejorados utilizando oocitos que expresan un enac humano y el uso de fenamilo para mejorar el efecto de intensificadores del enac en ensayos.
EP2086992B1 (en) * 2006-10-19 2015-07-15 Monell Chemical Senses Center Human salty taste receptor and methods of modulating salty taste perception
US20090210953A1 (en) * 2007-06-08 2009-08-20 Bryan Moyer Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release
TW200904981A (en) 2007-06-08 2009-02-01 Senomyx Inc Identification of TRPML3 (mcoln3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release
WO2010065863A2 (en) * 2008-12-05 2010-06-10 Senomyx, Inc. Assays for identifying genes encoding salty taste receptors and modulators
US20100319075A1 (en) * 2009-06-12 2010-12-16 Monell Chemical Senses Center STG Promoter And Its Use As A Marker For Taste And Oocyte Cells
SG175260A1 (en) 2009-09-29 2011-11-28 Ajinomoto Kk Method for screening for salty taste control substance
JP5627479B2 (ja) * 2011-01-24 2014-11-19 日清食品ホールディングス株式会社 Skn−1a/iノックアウトマウスを用いた味蕾細胞マーカー分子の探索方法
EP4194001B1 (en) 2015-04-22 2026-03-18 Cedars-Sinai Medical Center Enterically delivered bitter oligopeptides for the treatment of type 2 diabetes and obesity
US11547102B2 (en) 2017-12-28 2023-01-10 Nissin Foods Holdings Co., Ltd. Method for screening saltiness enhancer using saltiness receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750339A (en) * 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
US7041448B2 (en) * 2000-08-18 2006-05-09 The ML4 Foundation Gene encoding a new TRP channel is mutated in mucolipidosis IV
US20020164645A1 (en) * 2000-12-29 2002-11-07 The Regents Of The University Of California Assays for taste receptor cell specific ion channel
TW201022287A (en) * 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7368285B2 (en) * 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
WO2003004992A2 (en) * 2001-07-03 2003-01-16 The Regents Of The University Of California Mammalian sweet and amino acid heterodimeric taste receptors
DE10155130A1 (de) * 2001-11-12 2003-05-22 Max Delbrueck Centrum Verfahren zur Isolierung von Neuronen
US20050266442A1 (en) * 2004-03-25 2005-12-01 Rachel Squillace Immortalized human Tuberous Sclerosis null angiomyolipoma cell and method of use thereof

Also Published As

Publication number Publication date
MX2008015314A (es) 2008-12-12
US20080261824A1 (en) 2008-10-23
EP2024518A4 (en) 2010-05-26
IL195205A0 (en) 2009-08-03
WO2007146120A2 (en) 2007-12-21
AU2007258511A1 (en) 2007-12-21
CA2654552A1 (en) 2007-12-21
WO2007146120A3 (en) 2008-12-04
JP2009539377A (ja) 2009-11-19
EP2024518A2 (en) 2009-02-18
TW200813232A (en) 2008-03-16

Similar Documents

Publication Publication Date Title
Zhu et al. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice
Hashimoto et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Xu et al. Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF/Gabra1 changes in mice
Dione et al. Mgll knockout mouse resistance to diet-induced dysmetabolism is associated with altered gut microbiota
Ohba et al. GRIN 1 mutations cause encephalopathy with infantile‐onset epilepsy, and hyperkinetic and stereotyped movement disorders
WO2007146120A3 (en) Rationale, methods, and assays for identifying novel taste cell genes and salty taste receptor targets and assays using these identified genes or gene products
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
EA200900959A1 (ru) Ингибиторы мек
BR112015001642A2 (pt) triagem, diagnóstico e prognóstico de autismo e outros distúrbios de desenvolvimento
EP2061907A4 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
BRPI0507856A (pt) composição farmacêutica, e, processo para preparar o anticorpo abeta
EA200970112A1 (ru) Документ, снабженный идентифицирующими и верификационными данными
BRPI0515560A (pt) memantina para o tratamento de distúrbios comportamentais infantis
Martínez et al. Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo
Kodama et al. Higher dopamine release induced by less rather than more preferred reward during a working memory task in the primate prefrontal cortex
Caseris et al. French 2010–2011 measles outbreak in adults: report from a Parisian teaching hospital
Osugi et al. Cionin, a vertebrate cholecystokinin/gastrin homolog, induces ovulation in the ascidian Ciona intestinalis type A
Shin et al. Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats
Akgül et al. Toxoplasma gondii infection by serological and molecular methods in schizophrenia patients with and without suicide attempts: an age‐sex‐matched case‐control study
Chen et al. Identification and functional analysis of the cytolethal distending toxin gene from Avibacterium paragallinarum
Zhu et al. Application of omics in donkey meat research: a review
Gao et al. ER proteotoxic stress drives mitochondrial dysfunction in heat-stressed intestinal epithelial cells
WO2009151337A3 (en) Novel retinoid inducible factor and uses thereof
Kim et al. The effect of biocide chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) mixture on C2C12 muscle cell damage attributed to mitochondrial reactive oxygen species overproduction and autophagy activation
Fryar-Williams et al. Molecular Mechanism Biomarkers Predict Diagnosis in Schizophrenia and Schizoaffective Psychosis, with Implications for Treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application